Hoth Therapeutics Inc. [NASDAQ: HOTH] traded at a high on 02/23/21, posting a 7.39 gain after which it closed the day’ session at $2.47. The company report on February 23, 2021 that Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of HT-001 For Cancer Patients.
Hoth intends to pursue FDA Expedited Programs, such as Breakthrough Designation, pending generation of future clinical study data for HT-001.
Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, announced the successful completion of a pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding the Company’s development plan for their HT-001 product. The Pre-IND meeting was completed through written responses provided by the FDA Division of Dermatology and Dentistry on February 22, 2021.
The results of the trading session contributed to over 7868346 shares changing hands. Over the past one week, the price volatility of Hoth Therapeutics Inc. stands at 21.60% while the volatility over the past one month is 11.57%.
The market cap for HOTH stock reached $34.90 million, with 13.44 million shares outstanding and 6.70 million shares in the current float. Compared to the average trading volume of 3.48M shares, HOTH reached a trading volume of 7868346 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Hoth Therapeutics Inc. [HOTH]?
The Benchmark Company have made an estimate for Hoth Therapeutics Inc. shares, keeping their opinion on the stock as Speculative Buy, with their previous recommendation back on October 15, 2019.
The Average True Range (ATR) for Hoth Therapeutics Inc. is set at 0.29 The Price to Book ratio for the last quarter was 6.18, with the Price to Cash per share for the same quarter was set at 0.38.
How has HOTH stock performed recently?
Hoth Therapeutics Inc. [HOTH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.80. With this latest performance, HOTH shares gained by 6.47% in over the last four-week period, additionally sinking by 0.00% over the last 6 months – not to mention a drop of -43.22% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HOTH stock in for the last two-week period is set at 53.35, with the RSI for the last a single of trading hit 51.39, and the three-weeks RSI is set at 54.41 for Hoth Therapeutics Inc. [HOTH]. The present Moving Average for the last 50 days of trading for this stock 2.14, while it was recorded at 2.60 for the last single week of trading, and 2.34 for the last 200 days.
Hoth Therapeutics Inc. [HOTH]: Deeper insight into the fundamentals
Return on Total Capital for HOTH is now -604.87, given the latest momentum, and Return on Invested Capital for the company is -604.05. Return on Equity for this stock declined to -604.05, with Return on Assets sitting at -461.35.
Reflecting on the efficiency of the workforce at the company, Hoth Therapeutics Inc. [HOTH] managed to generate an average of -$2,568,212 per employee.Hoth Therapeutics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.60 and a Current Ratio set at 9.60.
Earnings analysis for Hoth Therapeutics Inc. [HOTH]
With the latest financial reports released by the company, Hoth Therapeutics Inc. posted -0.42/share EPS, while the average EPS was predicted by analysts to be reported at -0.14/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -200.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HOTH.
Insider trade positions for Hoth Therapeutics Inc. [HOTH]
There are presently around $1 million, or 2.50% of HOTH stock, in the hands of institutional investors. The top three institutional holders of HOTH stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 157,190, which is approximately 98.452% of the company’s market cap and around 37.89% of the total institutional ownership; VANGUARD GROUP INC, holding 49,687 shares of the stock with an approximate value of $0.12 million in HOTH stocks shares; and TWO SIGMA ADVISERS, LP, currently with $98000.0 in HOTH stock with ownership of nearly New of the company’s market capitalization.
Positions in Hoth Therapeutics Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 10 institutional holders increased their position in Hoth Therapeutics Inc. [NASDAQ:HOTH] by around 168,609 shares. Additionally, 4 investors decreased positions by around 21,193 shares, while 5 investors held positions by with 167,402 shares. The mentioned changes placed institutional holdings at 357,204 shares, according to the latest SEC report filing. HOTH stock had 7 new institutional investments in for a total of 82,450 shares, while 3 institutional investors sold positions of 14,609 shares during the same period.